Fresenius SE & Co. KGaA (BIT:1FRE)
Italy · Delayed Price · Currency is EUR | Market Cap | 22.95B +2.2% |
| Revenue (ttm) | 22.99B +3.0% |
| Net Income | 1.47B +248.3% |
| EPS | 2.60 +246.6% |
| Shares Out | n/a |
| PE Ratio | 15.61 |
| Forward PE | 11.25 |
| Dividend | 2.05 (5.06%) |
| Ex-Dividend Date | May 25, 2026 |
| Volume | n/a |
| Average Volume | 178 |
| Open | 40.50 |
| Previous Close | 40.04 |
| Day's Range | 40.50 - 40.50 |
| 52-Week Range | 39.20 - 52.36 |
| Beta | n/a |
| RSI | 36.82 |
| Earnings Date | May 6, 2026 |
About Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition prod... [Read more]
Financial Performance
In 2025, Fresenius SE & Co. KGaA's revenue was 22.87 billion, an increase of 4.19% compared to the previous year's 21.95 billion. Earnings were 1.26 billion, an increase of 168.37%.
Financial StatementsNews
Fresenius SE price target lowered to EUR 53 from EUR 57 at Citi
Citi lowered the firm’s price target on Fresenius SE (FSNUY) to EUR 53 from EUR 57 and keeps a Buy rating on the shares. Published first on TheFly – the
Fresenius SE price target lowered to EUR 56 from EUR 58 at Morgan Stanley
Morgan Stanley analyst Aisyah Noor lowered the firm’s price target on Fresenius SE (FSNUY) to EUR 56 from EUR 58 and keeps an Overweight rating on the shares. Published first
Fresenius SE price target raised to EUR 56.60 from EUR 53.60 at JPMorgan
JPMorgan raised the firm’s price target on Fresenius SE (FSNUY) to EUR 56.60 from EUR 53.60 and keeps an Overweight rating on the shares. Published first on TheFly – the
Fresenius SE price target raised to EUR 57 from EUR 56 at Deutsche Bank
Deutsche Bank analyst Falko Friedrichs raised the firm’s price target on Fresenius SE (FSNUY) to EUR 57 from EUR 56 and keeps a Buy rating on the shares. Published first
Fresenius SE price target raised to EUR 58 from EUR 56 at Morgan Stanley
Morgan Stanley analyst Aisyah Noor raised the firm’s price target on Fresenius SE (FSNUY) to EUR 58 from EUR 56 and keeps an Overweight rating on the shares. Published first
Fresenius SE price target raised to EUR 57 from EUR 52 at Citi
Citi raised the firm’s price target on Fresenius SE (FSNUY) to EUR 57 from EUR 52 and keeps a Buy rating on the shares. Published first on TheFly – the
Fresenius SE price target lowered to EUR 56 from EUR 57 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Fresenius SE (FSNUY) to EUR 56 from EUR 57 and keeps an Overweight rating on the shares. Published first on TheFly –
Fresenius SE price target raised to EUR 57 from EUR 56 at Morgan Stanley
Morgan Stanley analyst Robert Davies raised the firm’s price target on Fresenius SE (FSNUY) to EUR 57 from EUR 56 and keeps an Overweight rating on the shares. Published first
Fresenius SE price target raised to EUR 56 from EUR 53 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Fresenius SE (FSNUY) to EUR 56 from EUR 53 and keeps a Buy rating on the shares. Published first on TheFly –
Fresenius SE price target raised to EUR 53.60 from EUR 49.10 at JPMorgan
JPMorgan raised the firm’s price target on Fresenius SE (FSNUY) to EUR 53.60 from EUR 49.10 and keeps an Overweight rating on the shares. Published first on TheFly – the
Fresenius SE price target raised to EUR 53 from EUR 52 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Fresenius SE (FSNUY) to EUR 53 from EUR 52 and keeps a Buy rating on the shares. Published first on TheFly –
Fresenius SE price target raised to EUR 50 from EUR 48 at Morgan Stanley
Morgan Stanley analyst Robert Davies raised the firm’s price target on Fresenius SE (FSNUY) to EUR 50 from EUR 48 and keeps an Overweight rating on the shares. Published first
Fresenius SE price target raised to EUR 52 from EUR 43 at Citi
Citi raised the firm’s price target on Fresenius SE (FSNUY) to EUR 52 from EUR 43 and keeps a Buy rating on the shares. Published first on TheFly – the
Fresenius SE price target raised to EUR 48 from EUR 44 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Fresenius SE (FSNUY) to EUR 48 from EUR 44 and keeps an Overweight rating on the shares. Published first on TheFly –
Fresenius SE price target raised to EUR 50 from EUR 45 at Berenberg
Berenberg raised the firm’s price target on Fresenius SE (FSNUY) to EUR 50 from EUR 45 and keeps a Buy rating on the shares. Published first on TheFly – the
Fresenius SE price target lowered to EUR 49.10 from EUR 56.90 at JPMorgan
JPMorgan lowered the firm’s price target on Fresenius SE (FSNUY) to EUR 49.10 from EUR 56.90 and keeps an Overweight rating on the shares. Published first on TheFly – the
Fresenius posts profit beat in first quarter, confirms outlook
German healthcare group Fresenius beat analysts' adjusted operating profit expectations for the first quarter on Wednesday, citing a strong performance at its drug making division Kabi.
Fresenius SE price target raised to EUR 49 from EUR 43.50 at Barclays
Barclays analyst Hassan Al-Wakeel raised the firm’s price target on Fresenius SE (FSNUY) to EUR 49 from EUR 43.50 and keeps an Overweight rating on the shares. Published first on
Fresenius SE price target lowered to EUR 43.50 from EUR 44 at Barclays
Barclays lowered the firm’s price target on Fresenius SE (FSNUY) to EUR 43.50 from EUR 44 and keeps an Overweight rating on the shares. Published first on TheFly – the
Fresenius SE reinstated with a Buy at Erste Group
Erste Group reinstated coverage of Fresenius SE (FSNUY) with a Buy rating. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’
Fresenius SE price target raised to EUR 56.90 from EUR 41.90 at JPMorgan
JPMorgan raised the firm’s price target on Fresenius SE (FSNUY) to EUR 56.90 from EUR 41.90 and keeps an Overweight rating on the shares. Published first on TheFly – the
Fresenius SE Raises Guidance After Strong Kabi, Helios Performances
The healthcare company lifted its full-year guidance after a robust third quarter driven by Kabi and good organic growth at Helios.
Healthcare group Fresenius tops Q4 operating profit expectations
Fresenius reported a bigger-than-expected 13% jump in fourth-quarter operating profit on Wednesday, citing good earnings development across its businesses and progress in the operational turnaround at...
Fresenius perfectly positioned to combat health inequality, says CEO
Michael Sen, CEO at Fresenius, explains what the company is doing to help close the health care gap.
Fresenius to assess whether state aid impacts bonus, dividend payouts
German healthcare group Fresenius said it was examining whether the state aid it received to help offset high energy costs at its hospitals business would bar it from making management bonus and divid...